161 related articles for article (PubMed ID: 21406206)
1. Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region.
Himmelreich H; Mathys A; Wodnar-Filipowicz A; Kalberer CP
Hum Immunol; 2011 Jun; 72(6):470-8. PubMed ID: 21406206
[TBL] [Abstract][Full Text] [Related]
2. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
Front Immunol; 2018; 9():1282. PubMed ID: 29963042
[TBL] [Abstract][Full Text] [Related]
4. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.
López-Soto A; Folgueras AR; Seto E; Gonzalez S
Oncogene; 2009 Jun; 28(25):2370-82. PubMed ID: 19430493
[TBL] [Abstract][Full Text] [Related]
5. Limitation in use of luciferase reporter genes for 3'-untranslated region analysis.
Wang L; Zhang J; Zhang R; Xue F; Sun Y; Han X
Biotechnol Lett; 2007 Nov; 29(11):1691-6. PubMed ID: 17611725
[TBL] [Abstract][Full Text] [Related]
6. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.
Kamimura H; Yamagiwa S; Tsuchiya A; Takamura M; Matsuda Y; Ohkoshi S; Inoue M; Wakai T; Shirai Y; Nomoto M; Aoyagi Y
J Hepatol; 2012 Feb; 56(2):381-8. PubMed ID: 21756848
[TBL] [Abstract][Full Text] [Related]
7. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA.
Wang E; Ma WJ; Aghajanian C; Spriggs DR
Cancer Res; 1997 Dec; 57(23):5426-33. PubMed ID: 9393771
[TBL] [Abstract][Full Text] [Related]
8. EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells.
Kim H; Kim SH; Kim MJ; Kim SJ; Park SJ; Chung JS; Bae JH; Kang CD
J Immunother; 2011 May; 34(4):372-81. PubMed ID: 21499124
[TBL] [Abstract][Full Text] [Related]
9. Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.
Park MJ; Bae JH; Chung JS; Kim SH; Kang CD
Immunol Invest; 2011; 40(4):367-82. PubMed ID: 21314289
[TBL] [Abstract][Full Text] [Related]
10. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
11. Human CYP2E1 is regulated by miR-378.
Mohri T; Nakajima M; Fukami T; Takamiya M; Aoki Y; Yokoi T
Biochem Pharmacol; 2010 Apr; 79(7):1045-52. PubMed ID: 19945440
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction.
Bae JH; Kim SJ; Kim MJ; Oh SO; Chung JS; Kim SH; Kang CD
Cancer Sci; 2012 Jan; 103(1):7-16. PubMed ID: 21951556
[TBL] [Abstract][Full Text] [Related]
13. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
Bessoles S; Ni M; Garcia-Jimenez S; Sanchez F; Lafont V
Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
[TBL] [Abstract][Full Text] [Related]
15. miR-584 mediates post-transcriptional expression of lactoferrin receptor in Caco-2 cells and in mouse small intestine during the perinatal period.
Liao Y; Lönnerdal B
Int J Biochem Cell Biol; 2010 Aug; 42(8):1363-9. PubMed ID: 19665576
[TBL] [Abstract][Full Text] [Related]
16. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
Eleme K; Taner SB; Onfelt B; Collinson LM; McCann FE; Chalupny NJ; Cosman D; Hopkins C; Magee AI; Davis DM
J Exp Med; 2004 Apr; 199(7):1005-10. PubMed ID: 15051759
[TBL] [Abstract][Full Text] [Related]
17. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection.
Ebihara T; Masuda H; Akazawa T; Shingai M; Kikuta H; Ariga T; Matsumoto M; Seya T
Int Immunol; 2007 Oct; 19(10):1145-55. PubMed ID: 17878262
[TBL] [Abstract][Full Text] [Related]
18. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
[TBL] [Abstract][Full Text] [Related]
19. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor.
López-Soto A; Quiñones-Lombraña A; López-Arbesú R; López-Larrea C; González S
J Biol Chem; 2006 Oct; 281(41):30419-30. PubMed ID: 16901903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]